Findings of a 29% greater reduction in seizures at 4 months compared with controls led an FDA advisory panel to recommend approval of DBS in the ANT for severe and refractory partial seizures with or without secondary generalization. Medscape Medical News
In a trial of nondepressed patients with recent stoke, those who received escitalopram or problem-solving therapy were less likely to develop depression. Medscape Medical News
In this video blog, Dr. Mark Alberts results of the NEST II trial as presented at the 2009 International Stroke Conference Medscape Neurology & Neurosurgery
This study stands as a potentially very important advance -- not only in DMD, but as part of a broader quest for successful gene therapies. AccessMedicine from McGraw-Hill
A large study shows that older adults with dementia who start receiving antipsychotic drug therapy have an increased risk for hospitalization or death within 30 days. Medscape Medical News
